2010
DOI: 10.1590/s0037-86822010000400029
|View full text |Cite
|
Sign up to set email alerts
|

Cryptococcus gattii meningoencephalitis in an HIV-negative patient from the Peruvian Andes

Abstract: We report a case of an immunocompetent Peruvian patient from the Andes with a one-month history of meningoencephalitis. Cryptococcus gattii was identified from a cerebrospinal fluid culture through assimilation of D-proline and D-tryptophan as the single nitrogen source. Initially, the patient received intravenous antifungal therapy with amphotericin B. The patient was discharged 29 days after hospitalization and continued with oral fluconazole treatment for ten weeks. During this period, the patient showed cl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
5
0
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 9 publications
3
5
0
1
Order By: Relevance
“…In this study, the MIC value for fluconazole was 8.0 μg ml −1 . The Infectious Diseases Society of America standardised treatment of C. gattii with 0.7 mg kg −1 day −1 of amphotericin B intravenously, 100 mg kg −1 day −1 of 5‐flucytosine orally for 2 weeks, followed by 400–800 mg day −1 orally of fluconazole for at least 8 weeks . In the case reported herein, amphotericin B was used alone at an initial dose of 0.8 mg kg −1 .…”
Section: Discussionsupporting
confidence: 89%
See 3 more Smart Citations
“…In this study, the MIC value for fluconazole was 8.0 μg ml −1 . The Infectious Diseases Society of America standardised treatment of C. gattii with 0.7 mg kg −1 day −1 of amphotericin B intravenously, 100 mg kg −1 day −1 of 5‐flucytosine orally for 2 weeks, followed by 400–800 mg day −1 orally of fluconazole for at least 8 weeks . In the case reported herein, amphotericin B was used alone at an initial dose of 0.8 mg kg −1 .…”
Section: Discussionsupporting
confidence: 89%
“…Previous studies have shown that headache is the predominant clinical sign; roughly 60%–85% of patients affected by C. gattii present CNS involvement . In patients with meningoencephalitis, the most common symptoms are as follows: headache, fever, cranial neuropathy, high intracranial pressure, lethargy, signs of meningeal irritation and coma . In this case, at the time of admission to the clinic (HGU), the patient presented with severe headache, fever, syncopal episodes and progressive loss of vision and hearing.…”
Section: Discussionsupporting
confidence: 82%
See 2 more Smart Citations
“…1-Methyl-D-Trp is a useful immunotherapeutic agent for combination use with chemotherapy (Jia et al 2008). D-Trp can serve as a nitrogen source for Cryptococcus gatti meningoencephalitis (Gutierrez et al 2010). …”
Section: D-tryptophanmentioning
confidence: 99%